Report bodes ill for antioxidant supplementation.
Larkin
M
M
D000975:Antioxidants / Q000009:adverse effects / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D002170:Canada; D018890:Chemoprevention / Q000379:methods*; D002908:Chronic Disease; D006801:Humans; D018673:Nutrition Policy; D009751:Nutritional Requirements; D012643:Selenium / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014810:Vitamin E / Q000009:adverse effects / Q000627:therapeutic use*
D000975:Antioxidants; D014810:Vitamin E; D012643:Selenium; D001205:Ascorbic Acid